By next year, about two-thirds of American physicians will be working as salaried employees of large groups and hospitals. This movement has been underway for years. Over the last decade, the number of independent physicians was falling by about 2% a year. But these trends are now accelerating. 

The trade in inferior quality medicines kills innocent patients. Perhaps 15 percent of the global drug supply outside of advanced countries is counterfeit, rising in certain markets in parts of Africa and Asia to over 50 percent. But counterfeits are not the only low-quality drugs on the market.

India is the world's largest generic drugs manufacturing location but it has a significant problem with counterfeit and substandard drugs.

Two years from now we will likely be looking at an insurance market that has become worse, not better, with premiums higher and more Americans joining the rolls of the uninsured.

As ingenious, painstaking and justifiably attention-getting as domino swaps are, they should not blot out the dismal news that rates of kidney donation, from both living and deceased donors, fall woefully short of the need.

A significant portion of antimalarial drugs in Africa have been illegally diverted from the public sector, where they were intended to be dispensed free of charge in public health facilities, to the private sector.

India's continued rise as a pharmaceutical power is tainted by concerns about fake and substandard drugs, but a new report finds that private companies are finding innovative ways of preserving the identity of their products.

The Bush administration"s eRulemaking Initiative will have important implications for access to regulatory information for those who work on rules and those who are affected by rules.